Related Experiment Video
Updated: Aug 26, 2025
A High-Fidelity Porcine Model of Orthotopic Heart Transplantation Following Donation after Circulatory Death
Published on: June 6, 2025
How to improve results after DCD (donation after circulation death)
Maryne Lepoittevin1, Sébastien Giraud2, Thomas Kerforne3
1Unité UMR U1082, F-86000 Poitiers, France; Faculté de Médecine et de Pharmacie, Université de Poitiers, F-86000 Poitiers, France.
Insights
Organ donation after circulatory arrest offers a vital source for transplantation. Strategies are explored to mitigate warm ischemia-reperfusion injury and enhance organ quality for recipients.
Area of Science:
- Transplantation Medicine
- Organ Donor Management
- Immunology
Background:
- Global organ shortage necessitates exploring alternative donor sources.
- Donors after circulatory arrest (DCA) present unique challenges due to warm ischemia-reperfusion injury.
- Optimizing organ quality from DCAs is crucial for successful transplantation.
Purpose of the Study:
- To review key issues in utilizing organs from donors after circulatory arrest.
- To present strategies for improving organ quality throughout the transplantation process.
- To analyze technological and molecular advancements for organ preservation and evaluation.
Main Methods:
- Discussion of team organization, legislative, and ethical frameworks for DCA donation.
- Analysis of organ preservation techniques, including perfusion modalities.
- Review of emerging molecules and technologies for organ protection and assessment.
Main Results:
- Utilizing organs from donors after circulatory arrest is becoming routine.
- Therapeutic strategies and technological innovations can mitigate ischemia-reperfusion injury.
- Understanding pathophysiological mechanisms and innate immunity is key to improving outcomes.
Conclusions:
- Improving the quality and evaluation of organs from donors after circulatory arrest is essential.
- Advancements in perfusion, molecular therapies, and understanding immune responses offer promising prospects.
- Repositioning the use of DCA donors requires a comprehensive approach to organ management.
Abstract:
The shortage of organs for transplantation has led health professionals to look for alternative sources of donors. One of the avenues concerns donors who have died after circulatory arrest. This is a special situation because the organs from these donors are exposed to warm ischaemia-reperfusion lesions that are unavoidable during the journey of the organs from the donor to the moment of transplantation in the recipient. We will address and discuss the key issues from the perspective of team organization, legislation and its evolution, and the ethical framework. In a second part, the avenues to improve the quality of organs will be presented following the itinerary of the organs between the donor and the recipient. The important moments from the point of view of therapeutic strategy will be put into perspective. New connections between key players involved in pathophysiological mechanisms and implications for innate immunity and injury processes are among the avenues to explore. Technological developments to improve the quality of organs from these recipients will be analyzed, such as perfusion techniques with new modalities of temperatures and oxygenation. New molecules are being investigated for their potential role in protecting these organs and an analysis of potential prospects will be proposed. Finally, the important perspectives that seem to be favored will be discussed in order to reposition the use of deceased donors after circulatory arrest. The use of these organs has become a routine procedure and improving their quality and providing the means for their evaluation is absolutely inevitable.
